HAND2 Assists MYCN Enhancer Invasion to Regulate a Noradrenergic Neuroblastoma Phenotype
2023 · Cancer Research · 21 citations
https://doi.org/10.1158/0008-5472.can-22-2042
M
Ming Sun
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
87
Papers
227
Citations
8
h-index
8
i10-index
Ming Sun is an academic researcher from National Institutes of Health. The author has contributed to research in topics: CAR-T cell therapy research & Neuroblastoma Research and Treatments & Cancer Immunotherapy and Biomarkers. The author has an h-index of 8, co-authored 74 publications.
ORCID: 0000-0002-6313-4458Papers by this author
worksCombining selinexor with alisertib to target the p53 pathway in neuroblastoma
2022 · Neoplasia · 16 citations
https://doi.org/10.1016/j.neo.2022.100776
Lineage specific transcription factor waves reprogram neuroblastoma from self-renewal to differentiation
2024 · Nature Communications · 16 citations
https://doi.org/10.1038/s41467-024-47166-y
Additional file 1: Table S1. of LincRNAFEZF1-AS1 represses p21 expression to promote gastric cancer proliferation through LSD1-Mediated H3K4me2 demethylation
2017 · Figshare · 4 citations
https://doi.org/10.6084/m9.figshare.c.3696487_d3
Data from Cooperative Armoring of CAR and TCR T Cells by T Cell–Restricted IL15 and IL21 Universally Enhances Solid Tumor Efficacy
2024 · 0 citations
https://doi.org/10.1158/1078-0432.c.7181305
Supplementary Fig. S3 from Cooperative Armoring of CAR and TCR T Cells by T Cell–Restricted IL15 and IL21 Universally Enhances Solid Tumor Efficacy
2024 · 0 citations
https://doi.org/10.1158/1078-0432.25603447.v1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat